Literature DB >> 4290122

Herpes simplex encephalitis treated with intravenous idoxuridine.

A D Evans, O P Gray, M H Miller, E R Jones, R D Weeks, C E Wells.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4290122      PMCID: PMC1845071          DOI: 10.1136/bmj.2.5549.407

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Diagnostic cortical biopsy; a histological and chemical study.

Authors:  W BLACKWOOD; J N CUMINGS
Journal:  Lancet       Date:  1959-07-11       Impact factor: 79.321

2.  Initial clinical studies with 5-iodo-2'-deoxyuridine.

Authors:  P CALABRESI; S S CARDOSO; S C FINCH; M M KLIGERMAN; C F VON ESSEN; M Y CHU; A D WELCH
Journal:  Cancer Res       Date:  1961-05       Impact factor: 12.701

3.  Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine.

Authors:  H E KAUFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

4.  Agar diffusion method for detection and bioassay of antiviral antibiotics.

Authors:  E C HERRMANN; J GABLIKS; C ENGLE; P L PERLMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-03

5.  Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections.

Authors:  P Calabresi
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

6.  Cellular and antiviral effects of halogenated deoxyribonucleosides.

Authors:  W H Prusoff; Y S Bakhle; L Sekely
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

7.  Clinical experience with nucleosides in herpes simplex eye infections in man and animals.

Authors:  I H Leopold
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

8.  Herpes simplex encephalitis treated with systemic 5-iodo-2'deoxyuridine.

Authors:  C J Breeden; T C Hall; H R Tyler
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

9.  Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis.

Authors:  H KAUFMAN; E L MARTOLA; C DOHLMAN
Journal:  Arch Ophthalmol       Date:  1962-08
  9 in total
  12 in total

1.  Antiviral chemotherapeutic agents.

Authors:  J E Miller
Journal:  Can Med Assoc J       Date:  1968-10-12       Impact factor: 8.262

2.  Cytomegalovirus myocarditis.

Authors:  R S Wilson; T H Morris; J R Rees
Journal:  Br Heart J       Date:  1972-08

3.  Approach to diagnosis and treatment of herpes simplex encephalitis. A report of two cases.

Authors:  M J Gurwith; C E Harman; T C Merigan
Journal:  Calif Med       Date:  1971-12

4.  Immunofluorescence staining for the diagnosis of herpes encephalitis.

Authors:  A H Tomlinson; I J Chinn; F O MacCallum
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

5.  Herpes encephalitis. I. The clinical picture.

Authors:  A M Campbell
Journal:  Postgrad Med J       Date:  1969-06       Impact factor: 2.401

6.  Congenital cytomegalovirus infection treated with idoxuridine.

Authors:  A F Conchie; B W Barton; J O Tobin
Journal:  Br Med J       Date:  1968-10-19

7.  Electron microscopic observations on the virus particles in Herpes simplex encephalitis.

Authors:  S Roy; L Wolman
Journal:  J Clin Pathol       Date:  1969-01       Impact factor: 3.411

8.  Rapid diagnosis of herpesvirus hominis infections in superficial lesions by immunofluorescent antibody technics.

Authors:  P S Gardner; J McQuillin; M M Black; J Richardson
Journal:  Br Med J       Date:  1968-10-12

9.  Herpes encephalitis.

Authors: 
Journal:  Br Med J       Date:  1968-08-10

10.  Acute necrotizing encephalitis. Report of a case associated with polycythemia vera.

Authors:  G J Hum
Journal:  Calif Med       Date:  1968-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.